• PIRFENIDONE CHEMBL1256391 FDA ApprovedAntineoplasticImmunotherapy

    Alternate Names:

    Pirfenidone
    AMR-69
    C2635
    Esbriet
    53179-13-8
    DB04951
    PIRFENIDONE [USAN:INN]
    MLS000860042
    BIO1_001375
    EN000704
    P2116_SIGMA
    2(1H)-PYRIDONE, 5-METHYL-1-PHENYL-
    NCGC00024992-03
    5-METHYL-1-PHENYL-1H-PYRIDIN-2-ONE
    PIRFENIDONA
    PIRESPA
    2(1H)-PYRIDINONE, 5-METHYL-1-PHENYL-
    PIRFENIDONUM [INN-LATIN]
    F-647
    CID40632
    AMR 69
    PIRFENIDONE (JAN/USAN/INN)
    AC-6797
    AC1L2454
    5-METHYL-1-PHENYLPYRIDIN-2-ONE
    40632
    FT-0082541
    PIRFENIDONUM
    D01583
    5-METHYL-1-PHENYL-2(1H)-PYRIDONE
    KS-5041
    LS-133834
    TOCRIS-1093
    ZINC00001958
    BRD-K96862998-001-03-1
    LOPAC-P-2116
    BIO1_000886
    DCL000932
    NCGC00015806-05
    SMR000326900
    NCGC00024992-02
    46500438
    EU-0100907
    PIRFENIDONA [INN-SPANISH]
    5-21-07-00197 (BEILSTEIN HANDBOOK REFERENCE)
    S-7701
    NCGC00015806-01
    5-METHYL-1-PHENYL-2-(1H)-PYRIDONE
    NCGC00024992-01
    NCGC00015806-03
    P 2116
    PIRFENIDONE (DESKAR)
    BIO1_000397
    BRN 1526549
    LOPAC0_000907
    DESKAR
    C093844
    I01-1466
    C12H11NO
    5-METHYL-1-PHENYLPYRIDIN-2(1H)-ONE
    3B3-004809
    A829431
    5-?METHYL-?1-?PHENYL-?2(1H)-?PYRIDI
    M-2515
    J90039
    P1871
    FT-0602686
    4CH-013041
    ST2418816
    KB-246459
    AB0006721
    ZB000448
    SC-17366
    HE349242
    HE141720
    HE141719
    HE001979
    H960
    BR-72929
    BC678265
    AK-72929
    AJ-08117
    5-METHYL-N-PHENYL-2-1H-PYRIDONE
    NCGC00015806-06
    NCGC00015806-04
    NCGC00015806-02
    5-METHYL-1-PHENYL-2-(1H)-PYRIDINONE;
    RTR-018809
    RP24541
    NSC-748456
    LP00907
    CS18350
    CS-2905
    CCG-204989
    AN-5207
    AM84939
    AB07515
    TOX21_110225_1
    AKOS006273697
    NSC748456
    MFCD00866047
    CP0088
    BDBM50005201
    ANW-41906
    TOX21_110225
    TOX21 110225
    HY-B0673
    EBD52457
    AOB31717
    HMS3372A08
    HMS3267I06
    HMS3262F16
    HMS2234G24
    MOLPORT-003-666-737
    CTK8B3176
    CHEBI:32016
    ZINC1958
    GTPL7532
    AMR69
    SCHEMBL4708
    ACMC-209T1G
    D7NLD2JX7U
    PERFENIDONE
    ESBRIET (TN)
    5-METHYL-N-PHENYL-2-1H-PYRIDONE-D5 ( PIRFENIDONE-D5 )
    ESBRIETREG
    CAS-53179-13-8
    5-METHYL-1-PHENYL-1,2-DIHYDROPYRIDIN-2-ONE
    DSSTOX_GSID_45183
    DSSTOX_RID_80731
    DSSTOX_CID_25183
    ISWRGOKTTBVCFA-UHFFFAOYSA-N
    5-METHYL-1-PHENYL-PYRIDIN-2-ONE
    5-METHYL-1-PHENYL-2-PYRIDONE
    UNII-D7NLD2JX7U
    5-METHYL-1-PHENYL-2-PYRIDINONE
    5-METHYL-1-PHENYL-2(1H)-PYRIDINONE

    Drug Info:

    Drug Categories tumor necrosis factor alpha (tnf-α) inhibitors
    Drug Categories therapeutic uses
    Drug Categories sensory system agents
    Drug Categories pyridines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories peripheral nervous system agents
    Drug Categories immunosuppressive agents
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories antirheumatic agents
    Drug Categories antineoplastic and immunomodulating agents
    Drug Categories antineoplastic agents
    Drug Categories anti-inflammatory agents, non-steroidal
    Drug Categories anti-inflammatory agents
    Drug Categories analgesics, non-narcotic
    Drug Categories analgesics
    Drug Groups investigational
    Drug Type small molecule
    FDA Approval not approved
    Drug Class small molecule
    Drug Indications for treatment of fibrotic conditions
    (1 More Sources)